The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: A qualitative report

Sexual Health

Volumn 9, Issue 5, 2012, Pages 407-413

  Herrmann, Susan ^a   Wardrop, Joan ^b   John, Mina ^a,c   Gaudieri, Silvana ^d   Lucas, Michaela ^a   Mallal, Simon ^a   Nolan, David ^a,c  

^a MURDOCH UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

AIDS; antiretroviral therapy; generic drugs; guest workers; immigration; stigma

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; EFAVIRENZ; EMTRICITABINE; GENERIC DRUG; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ATTITUDE TO AIDS; AUSTRALIA; CD4 LYMPHOCYTE COUNT; CITIZENSHIP; CLINICAL ARTICLE; CONFIDENTIALITY; DISEASE TRANSMISSION; EMPLOYMENT; FAMILY; FEAR; FEMALE; FOREIGN WORKER; FRIEND; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; IMMIGRATION; INTERVIEW; MALE; MEDICARE; PATIENT COMPLIANCE; QUALITATIVE RESEARCH; REVIEW; SELF REPORT; SPOUSE; STIGMA; STUDENT; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AFRICA, EASTERN; AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; ASIA; ATTITUDE TO HEALTH; CONFIDENTIALITY; DRUG COSTS; DRUGS, GENERIC; ELIGIBILITY DETERMINATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MEDICAL ASSISTANCE; MEDICATION ADHERENCE; NATIONAL HEALTH PROGRAMS; PREJUDICE; SOCIAL STIGMA; TRANSIENTS AND MIGRANTS; WESTERN AUSTRALIA;

EID: 84867640529     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH11181     Document Type: Review

References (28)

1. Combs BC, Giele CM. An increase in overseas acquired HIV infections among heterosexual people in Western Australia. Sex Health 2009; 6(1):3 5-9. doi:10.1071/SH08010
2. The International Labour Office. International labour conference report VI International Labour Conference 98th session. Geneva: International Labour Organisation; 2009.
3. Department of Immigration and Citizenship (DOIAC). Immigration update July to December 2010. Canberra: DOIAC; 2010.
4. Department of Immigration and Citizenship (DOIAC). Form 1071i health requirement for permanent entry into Australia. Canberra: DOIAC; 2010. Available online at: http://www.immi.gov.au/media/fact-sheets/22health.htm [verified March 2011].
5. 't Hoen EFM. The global politics of pharmaceutical monopoly power. Diemen, Netherlands: AMB Publishers, University of Amsterdam; 2009. Available online at: www.msfaccess.org/content/global-politics-pharmaceutical-monopoly- power [verified February 2012].
6. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee - a Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000; 12(3):2 55-66. doi:10.1080/ 09540120050042891 (Pubitemid 30426745)
7. Justice AC, Holmes W, Gifford AL, Rabeneck L, Zackin R, Sinclair G, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001; 54: S77-90. doi:10.1016/S0895-4356(01)00449-8 (Pubitemid 34013693)
8. Duracinsky M, Herrmann S, Berzins B, Armstrong A, Kohli R, Le Coeur S, et al. The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS. J Acquir Immune Defic Syndr 2012; 59:4 98-505.
9. Carrillo JE, Green AR, Betancourt Jr. Cross-cultural primary care: a patient-based approach. Ann Intern Med 1999; 130(10):8 29-34. (Pubitemid 29231152)
10. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375(9731):2 092-8. doi:10.1016/S0140-6736(10)60705-2
11. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338(13):8 53-60. doi:10.1056/NEJM199803263381301 (Pubitemid 28135961)
12. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE 2008; 3(7): e2783. doi:10.1371/journal.pone.0002783
13. Körner H. HIV and migration: two major uncertainties for people from culturally and lingusitically diverse backgrounds. Sydney: National Centre in HIV Social Research University of NSW; 2005.
14. Körner H. 'If I had my residency I wouldn't worry': negotiating migration and HIV in Sydney, Australia. Ethn Health 2007; 12(3):2 05-25. doi:10.1080/13557850701235093 (Pubitemid 46570234)
15. Körner H. Negotiating cultures: disclosure of HIV-positive status among people from minority ethnic communities in Sydney. Cult Health Sex 2007; 9(2):1 37-52. doi:10.1080/13691050600975462 (Pubitemid 46359061)
16. Herrmann S, McKinnon E, John M, Hyland N, Martinez OP, Cain A, et al. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care. Intern Med J 2008; 38(1):8-15.
17. Waldrop-Valverde D, Jones DL, Jayaweera D, Gonzalez P, Romero J, Ownby RL. Gender differences in medication management capacity in HIV infection: the role of health literacy and numeracy. AIDS Behav 2009; 13(1):4 6-52. doi:10.1007/s10461-008-9425-x
18. Bulsara C, McKenzie A, Sanfilippo F, Holman CDJ, Emery JE. Not the full Monty: a qualitative study of seniors' perceptions of generic medicines in Western Australia. Aust J Primary Health 2010; 16(3):2 40-5. doi:10.1071/PY10006
19. Lemoh CN, Baho S, Grierson J, Hellard M, Street A, Biggs BA. African Australians living with HIV: a case series from Victoria. Sex Health 2010; 7(2):1 42-8. doi:10.1071/SH09120
20. Orton LC. Seeking asylum and living with HIV: an ethnographic study. Manchester: The University of Manchester; 2009.
21. Posse M, Meheus F, Van Asten H, Van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment: a review of recent studies in developing countries. Trop Med Int Health 2008; 13:9 04-13. doi:10.1111/j.1365-3156.2008. 02091.x (Pubitemid 351813518)
22. Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care 2009; 21(6):7 42-53.
23. Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav 2009; 13(6):1 160-77. doi:10.1007/s10461-009-9593-3
24. Stafford A. HIV migrants to be watched. The Age; 31 May 2007: 31.
25. Antonovsky A. The structural sources of salutogenic strengths. In Cooper CL, Pavne R, editors. Personality and stress: individual differences in the stress process. Chichester: Wiley; 1991. p. 97-102.
26. Bonnano GA. Loss, trauma and human resilience. Am Psychol 2004; 59(1):2 0-8.
27. Hood JE, Friedman AL. Unveilling the hidden epidemic: a review of stigma associated with sexually transmissable infections. Sex Health 2011; 8:1 59-70. doi:10.1071/SH10070
28. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2011. Sydney: The Kirby Institute, University of New South Wales; 2011.